Showing results (151-160 of 11,019) with videos related to
Sort By:
Pageof 1,102
Journal of Cardiac Failure|August 2, 2017
Why Has a Run-In Period Been a Design Element in Most Landmark Clinical Trials? Analysis of the Critical Role of Run-In Periods in Drug DevelopmentMilton PackerDiabetes, Obesity & Metabolism|December 12, 2017
Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetesMilton PackerAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2020
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia MimeticsMilton PackerAmerican Journal of Nephrology|May 26, 2023
Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal AnemiaMilton PackerJACC. Basic to Translational Science|October 5, 2020
Mutual Antagonism of Hypoxia-Inducible Factor Isoforms in Cardiac, Vascular, and Renal DisordersMilton PackerNature Reviews. Cardiology|January 7, 2023
SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolismMilton PackerFrontiers in Neuroendocrinology|February 12, 2011
Developmental, sexual and reproductive neuroendocrinology: historical, clinical and ethical considerationsMilton DiamondCardiovascular Diabetology|September 26, 2019
Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissueMilton PackerPublic Health Reports (Washington, D.C. : 1974)|January 19, 2006
Pregnancy Risk Assessment Monitoring System (PRAMS): possible new roles for a national MCH data systemMilton KotelchuckPageof 1,102